Korea United Pharm, 1Q26 Preliminary: Rev +3.5%, OP -18.3%, NP +10.5%
-
Revenue: 73,817 million KRW (YoY +3.5%, QoQ +1.6%)
-
Operating profit: 11,256 million KRW (YoY -18.3%, QoQ -10.2%) - profitability decline due to increased costs
-
Pre-tax profit: 17,200 million KRW (YoY +11.4%, QoQ +24.6%) - increase in non-operating income
-
Net profit: 13,984 million KRW (YoY +10.5%, QoQ +28.0%) - significant improvement
-
These figures are preliminary and subject to change upon external audit
KOSPI Filing Information
-
Filing: Preliminary Operating Results (Fair Disclosure)
-
Company: KOREA UNITED PHARM (033270)
-
Submission: KOREA UNITED PHARM INC
-
Receipt: 04-30-2026
-
Under KRX KOSPI Market Division